 |
|
|
| |
High SVR12 Rates in HCV Genotype 1b-Infected Patients Receiving Ombitasvir/ABT-450/r and Dasabuvir With or Without Ribavirin Regardless of Baseline Characteristics
|
| |
| |
Reported by Jules Levin
54th Interscience Conference on Antimicrobial Agents & Chemotherapy
Washington, D.C., 07 September 2014
David Bernstein, Frederik Nevens, Jeffrey V. Enejosa, Federico Rodriguez-Perez, Resat Ozaras, Christophe Moreno, Maurizia R. Brunetto, Martin King, Daniel E. Cohen
|
| |
|
|
|
|
|
